SpareBank 1 Østlandet (SPOL)
Oslo Børs · Norway · prices in NOK · close of 27 Oct 2026
Key indicators
| Last close | NOK 204.60 |
|---|---|
| 52-week range | 173.00 – 215.70 |
| Return, 1 month / 3 months | −1.5% / +5.8% |
| Return, 1 year / 3 years | +21.5% / +99.5% |
| Trend | Uptrend |
| RSI (14) | 59 |
| Volatility (1 year) | 19.1% |
| Worst drawdown (1 year) | -12.6% |
| Average daily value traded | 6.71M NOK |
| Dividend yield | 6.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
SpareBank 1 Østlandet is a Norwegian savings bank based in Hamar that serves personal customers and small and medium-sized businesses across the eastern part of the country. It provides everyday banking such as mortgages, savings accounts, payment services and cards, along with insurance and pension products offered through the SpareBank 1 alliance. For businesses it lends and offers cash management and advisory services. The bank also operates through local branches and digital channels, and part of its earnings supports community and cultural causes in its region.
The shares are listed on the Oslo Børs in Norway under the code SPOL, and the price on this page is in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
SpareBank 1 Østlandet (SPOL) trades on the Oslo Børs in Norway. It last closed at NOK 204.60 on 27 October 2026.
Its price-based Market X-Ray is 73 out of 100 (a strong price profile), ranking 40 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 21.5% and over the last three months it rose 5.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Oslo Børs
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 70 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 4.9% | ||
| From 52-week high | -4.6% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 5.8% | ||
| 6-month return | 1.7% | ||
| 12-month return, skipping the last month | 23.3% | ||
| Stability (higher is calmer) | 91 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 19.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -12.6% | ||
| Liquidity | 65 · Fair | Moderate trading activity. | |
| Average daily value traded | 6.71M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | 72 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 6.2% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.4% |
|---|---|
| 1 month | −1.5% |
| 3 months | +5.8% |
| 6 months | +1.7% |
| 1 year | +21.5% |
| 3 years | +99.5% |
| 5 years | +100.3% |
Signals
| 50-day / 200-day average | 200.84 / 195.06 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.85 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Mar 2026 | NOK 12.7000 |
| 28 Mar 2025 | NOK 10.3000 |
| 22 Mar 2024 | NOK 7.8000 |
| 31 Mar 2023 | NOK 6.8000 |
| 30 Mar 2022 | NOK 6.0000 |
| 2 Nov 2021 | NOK 3.0400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Børs; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.